EPISODE · May 27, 2026 · 5 MIN
CHMP Pipeline Surge, NICE Threshold Jump, JCA Device Push
Episode 11 — 27 May 2026 EMA's CHMP recommended eight medicines including first-ever PROS treatment while NICE raised cost-effectiveness thresholds to £25,000-35,000 per QALY. The EU's Joint Clinical Assessment framework expands into medical devices with five assessments planned for June 2026. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
What this episode covers
Episode 11 — 27 May 2026 EMA's CHMP recommended eight medicines including first-ever PROS treatment while NICE raised cost-effectiveness thresholds to £25,000-35,000 per QALY. The EU's Joint Clinical Assessment framework expands into medical devices with five assessments planned for June 2026. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
NOW PLAYING
CHMP Pipeline Surge, NICE Threshold Jump, JCA Device Push
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m